Spain’s Rovi says possible Moderna vaccine contamination sent to Japan under probe

Published: Updated:

Spanish pharma company Rovi said on Thursday the potential contamination of some doses of the coronavirus vaccine which it manufactures for Moderna was under investigation and appeared limited to some batches for Japan.

A spokesperson for the Madrid-listed company, which handles the final fill-and-finish stage for customers outside of the United States, said production had not been halted at its plants.

Read the latest updates in our dedicated coronavirus section.

Japan suspended the use of 1.63 million doses of Moderna Inc's COVID-19 vaccine on Thursday, more than a week after the domestic distributor received reports of contaminants in some vials.

For the latest headlines, follow our Google News channel online or via the app.

Both Japan and Moderna said that no safety or efficacy issues had been identified and that the suspension was just a precaution. But the move prompted several Japanese companies to cancel worker vaccinations planned for Thursday.

Read more:

Misinformation about COVID-19, vaccine driving increase in cases: WHO official

Unvaccinated people 29 times more likely to be hospitalized with COVID-19: CDC study

Scientists discover antibody that works against broad number of COVID-19 variants

Top Content Trending